Source: Outsourcing-Pharma

PharmInvent: UK CRO Ergomed buys out competing Pharmacovigilance firm in Prague for £6.8m

UK based clinical research organization (CRO), Ergomed, has bought out the Czech PharmInvent as a 'bolt on' to its own pharmacovigilance subsidiary, PrimeVigilance.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Jan Petracek's photo - CEO of PharmInvent

CEO

Jan Petracek

CEO Approval Rating

69/100

Read more